silybin has been researched along with Diabetes Mellitus, Type 2 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caflisch, A; Di Fabio, G; García-Viñuales, S; Ilie, IM; Milardi, D; Romanucci, V; Santoro, AM; Zarrelli, A | 1 |
| Du, Q; Fujisaki, H; Hattori, S; Hayashi, T; Ikejima, T; Liu, P; Liu, W; Ma, K; Mizuno, K; Wu, X | 1 |
| Jin, L; Liang, G; Lv, Y; Wang, Y | 1 |
| Gao, M; Hayashi, T; Ikeda, K; Ikejima, T; Li, D; Negishi, H; Sun, Y; Xu, F; Yang, J; Zhang, X | 1 |
| Ahmad, J; Alam, K; Arif, Z; Neelofar, K | 1 |
| Bouderba, S; Detaille, D; Koceïr, EA; Sanchez-Martin, C; Villanueva, GR | 1 |
| Evangelopoulos, AA; Kazazis, CE; Kollas, A; Vallianou, NG | 1 |
| Bosco, P; Di Giacomo, C; Galvano, F; La Delia, F; Li Volti, G; Malaguarnera, M; Marrazzo, G; Nicolosi, A; Scapagnini, G | 1 |
| Beccarello, A; Crepaldi, G; De Monte, A; Donadon, V; Lirussi, F; Velussi, M; Zanette, G | 1 |
| McCarty, MF | 1 |
1 review(s) available for silybin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The therapeutic potential of milk thistle in diabetes.
Topics: Animals; Anti-Obesity Agents; Diabetes Mellitus; Diabetes Mellitus, Type 2; Flavonolignans; Humans; Hypoglycemic Agents; Phytotherapy; Plant Extracts; PPAR gamma; Rats; Seeds; Silybin; Silybum marianum; Silymarin | 2014 |
1 trial(s) available for silybin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.
Topics: Antioxidants; beta-Cyclodextrins; Blood Glucose; C-Peptide; Cholesterol, HDL; Cyclodextrins; Diabetes Mellitus, Type 2; Double-Blind Method; Female; gamma-Glutamyltransferase; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Liver Diseases, Alcoholic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Placebos; Silybin; Silymarin; Triglycerides | 2002 |
8 other study(ies) available for silybin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Silybins inhibit human IAPP amyloid growth and toxicity through stereospecific interactions.
Topics: Amyloid; Diabetes Mellitus, Type 2; Humans; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Silybin | 2022 |
Silibinin alleviates ferroptosis of rat islet β cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1/parkin-mediated mitophagy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Ferroptosis; Glucose; Mitophagy; Palmitic Acid; Protein Kinases; Rats; Reactive Oxygen Species; Silybin; Ubiquitin-Protein Ligases | 2023 |
Revealing the Mechanism of EGCG, Genistein, Rutin, Quercetin, and Silibinin Against hIAPP Aggregation via Computational Simulations.
Topics: Catechin; Diabetes Mellitus, Type 2; Genistein; Humans; Islet Amyloid Polypeptide; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Quercetin; Rutin; Silybin | 2020 |
Silibinin decreases hepatic glucose production through the activation of gut-brain-liver axis in diabetic rats.
Topics: Animals; Brain; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Supplements; Duodenum; Gastrointestinal Tract; Glucagon-Like Peptide-1 Receptor; Gluconeogenesis; Hyperglycemia; Hypoglycemic Agents; Liver; Liver Glycogen; Male; Neurons; Obesity; Rats, Sprague-Dawley; Rats, Zucker; Silybin; Solitary Nucleus; Specific Pathogen-Free Organisms; Vagotomy | 2018 |
Inhibitory effect of silibinin on Amadori-albumin in diabetes mellitus: A multi-spectroscopic and biochemical approach.
Topics: Arginine; Circular Dichroism; Diabetes Mellitus, Type 2; Glycosylation; Humans; Lysine; Protective Agents; Serum Albumin, Human; Silybin; Spectrophotometry, Ultraviolet | 2019 |
Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Disease Progression; Fatty Liver; Gerbillinae; Glutathione; Glutathione Peroxidase; Humans; Insulin; Lipids; Liver; Metabolic Syndrome; Obesity; Oxidative Stress; Silybin; Silymarin; Superoxide Dismutase | 2014 |
Neuroprotective effect of silibinin in diabetic mice.
Topics: Animals; Antioxidants; Body Weight; Brain; Brain Chemistry; Diabetes Mellitus, Type 2; DNA Damage; Drug Evaluation, Preclinical; Heme Oxygenase-1; Lipid Peroxidation; Membrane Proteins; Metalloporphyrins; Mice; Mice, Knockout; Mice, Mutant Strains; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Receptors, Leptin; Silybin; Silymarin | 2011 |
Potential utility of natural polyphenols for reversing fat-induced insulin resistance.
Topics: Adipocytes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Flavonoids; Humans; I-kappa B Kinase; Insulin Resistance; Models, Biological; Phenols; Polyphenols; Probenecid; Protein Serine-Threonine Kinases; Resveratrol; Silybin; Silymarin; Stilbenes | 2005 |